Biotech

Helix BioPharma Corp. Announces Fiscal 2013 Results

AURORA, ON: ...

Critical Outcome Technologies Announces Warrant Expiry Date Amendment

LONDON, ONTARIO: ...

LifeSci Advisors Initiates Coverage of Aradigm Corporation

NEW YORK, NY: Phase III Program in Bronchiectasis Planned to Launch in 2014; Recent Partnership With Grifols Worth Up to $90 Million Plus Tiered Royalties; Report Available for Download at http://lifesciadvisors.co ...

Lorus to Focus LOR-253 Development on AML Based on Genetic Insights Into the Causes of Certain Hematologic Cancers

TORONTO, ONTARIO: Silencing of the KLF4 Tumor Suppressor by CDX2 is a Critical Oncogenic Event in AML; LOR-253 Can Reactivate the Silenced KLF4 Gene Brian Druker, M.D. Appointed Chair of the Newly-Formed Scientific Adv ...

Second Annual Leadership Summit for Interventional Cardiologists Held in San Francisco

SAN FRANCISCO, CA: Faculty of Recognized Leadership Experts From Brandeis University, Yale University, Vocera Communications and The Medicines Company Join Panel of Leading Interventional Cardiologists From France, the ...

Theravance Appoints Jeff Jonker Senior Vice President, Corporate and Business Development

SOUTH SAN FRANCISCO, CA: ...

Lorus Therapeutics Appoints New Chief Executive Officer

TORONTO, ONTARIO: William G. Rice, Ph.D. Appointed CEO and Chairman of the Board Daniel D. Von Hoff, M.D., FACP to Serve as Key Advisor US Biotechnology Industry Veteran Brings Extensive Clinical Development and Capita ...

Alberta Innovates Bio Solutions: Public Lectures Featuring Jay Ingram

CALGARY, ALBERTA: ...

Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock

BERKELEY, CA: ...

Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results and Corporate Update on November 12, 2013

CAMBRIDGE, MA: ...